Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP284541.RAHSNQ_SCp2cJzx1qh7SA6-rOCgm4PxlZyrpln-R24aQE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP284541.RAHSNQ_SCp2cJzx1qh7SA6-rOCgm4PxlZyrpln-R24aQE130_assertion type Assertion NP284541.RAHSNQ_SCp2cJzx1qh7SA6-rOCgm4PxlZyrpln-R24aQE130_head.
- NP284541.RAHSNQ_SCp2cJzx1qh7SA6-rOCgm4PxlZyrpln-R24aQE130_assertion description "[KRAS2 mutations were seen in 5/51 (10%) MSI-positive carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284541.RAHSNQ_SCp2cJzx1qh7SA6-rOCgm4PxlZyrpln-R24aQE130_provenance.
- NP284541.RAHSNQ_SCp2cJzx1qh7SA6-rOCgm4PxlZyrpln-R24aQE130_assertion evidence source_evidence_literature NP284541.RAHSNQ_SCp2cJzx1qh7SA6-rOCgm4PxlZyrpln-R24aQE130_provenance.
- NP284541.RAHSNQ_SCp2cJzx1qh7SA6-rOCgm4PxlZyrpln-R24aQE130_assertion SIO_000772 11746970 NP284541.RAHSNQ_SCp2cJzx1qh7SA6-rOCgm4PxlZyrpln-R24aQE130_provenance.
- NP284541.RAHSNQ_SCp2cJzx1qh7SA6-rOCgm4PxlZyrpln-R24aQE130_assertion wasDerivedFrom befree-20140225 NP284541.RAHSNQ_SCp2cJzx1qh7SA6-rOCgm4PxlZyrpln-R24aQE130_provenance.
- NP284541.RAHSNQ_SCp2cJzx1qh7SA6-rOCgm4PxlZyrpln-R24aQE130_assertion wasGeneratedBy ECO_0000203 NP284541.RAHSNQ_SCp2cJzx1qh7SA6-rOCgm4PxlZyrpln-R24aQE130_provenance.